Biomedical Engineering Reference
In-Depth Information
234. Brackenbury WJ, Chioni AM, Diss JK, Djamgoz MB (2007) The neonatal splice variant of
Na
V
1.5 potentiates
in vitro
invasive behaviour of MDA-MB-231 human breast cancer cells.
Breast Cancer Res Treat 101:149-160
235. Anderson JD, Hansen TP, Lenkowski PW, Walls AM, Choudhury IM, Schenck HA, Friehling
M, Holll GM, Patel MK, Sikes RA, Brown ML (2003) Voltage-gated sodium channel
blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3.
Mol Cancer Ther 2:1149-1154
236. Brown ML, Zha CC, Van Dyke CC, Brown GB, Brouillette WJ (1999) Comparative
molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium
channel. J Med Chem 42:1537-1545
237. Sikes RA, Walls AM, Brennen WN, Anderson JD, Choudhury-Mukherjee I, Schenck HA,
Brown ML (2003) Therapeutic approaches targeting prostate cancer progression using novel
voltage-gated ion channel blockers. Clin Prostate Cancer 2:181-187
238. Rampe D, Murawsky MK, Gran J, Lewis EW (1998) The antipsychotic agent sertindole is a
high affinity antagonist of the human cardiac potassium channel HERG. J Pharmacol Exp
Ther 286:788-793
239. Laniado ME, Lalani EN, Fraser SP, Grimes JA, Bhagal G, Djamgoz MB, Abel PD (1997)
Expression and functional analysis of voltage-activated Na
+
channels in human prostate
cancer cell lines and their contribution to invasion
in vitro
. Am J Pathol 150:1213-1221
